Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myriad Genetics

9.85
-0.1350-1.35%
Volume:87.83K
Turnover:868.22K
Market Cap:898.94M
PE:-6.98
High:10.06
Open:9.98
Low:9.80
Close:9.98
Loading ...

Why Myriad Genetics (MYGN) Shares Are Plunging Today

StockStory
·
26 Feb

Myriad Genetics Price Target Cut to $19.00/Share From $27.00 by Raymond James

Dow Jones
·
26 Feb

Myriad Genetics Is Maintained at Neutral by UBS

Dow Jones
·
25 Feb

Myriad Genetics, Inc. (MYGN): AI-Driven Precision Medicine for Prostate Cancer

Insider Monkey
·
25 Feb

Stock Track | Myriad Genetics Plummets 25% on Q4 Earnings Decline and Q1 Guidance Miss amid UnitedHealthcare Headwinds

Stock Track
·
25 Feb

UBS Adjusts Price Target on Myriad Genetics to $16 From $18, Maintains Neutral Rating

MT Newswires Live
·
25 Feb

Stock Track | Myriad Genetics Plunges Over 10% on Q1 Guidance Miss, UnitedHealthcare Headwinds

Stock Track
·
25 Feb

Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday Amid Underwhelming Economic Data, Renewed Trade Tensions

MT Newswires Live
·
25 Feb

Q4 2024 Myriad Genetics Inc Earnings Call

Thomson Reuters StreetEvents
·
25 Feb

Myriad Genetics Inc : Raymond James Cuts Target Price to $19 From $27

THOMSON REUTERS
·
25 Feb

Myriad Genetics Appoints Sam Raha as Chief Executive

MT Newswires Live
·
25 Feb

Myriad Genetics Q4 Adjusted Earnings Decline, Revenue Increases; Full-Year Guidance Reiterated

MT Newswires Live
·
25 Feb

U.S. RESEARCH ROUNDUP-Domino's Pizza, Owens Corning, Ventas

Reuters
·
25 Feb

Myriad Genetics Inc (MYGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
25 Feb

Myriad Genetics Inc : TD Cowen Cuts Target Price to $16 From $17

THOMSON REUTERS
·
25 Feb

Myriad Genetics Reports Strong Revenue Growth in 2024

TIPRANKS
·
25 Feb